We have provided a publicly available three-biomarker framework to determine the extent of host response dysregulation with potential value for precision-guided immunomodulatory therapy.
The Lancet Respiratory Medicine published a clinical update in Critical Care on 16 Mar 2026.
The item focuses on Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial.
Review the original article for the full source wording and details.